Oncostatin M is a FIP1L1/PDGFRA-dependent mediator of cytokine production in chronic eosinophilic leukemia.

about

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA

P2860

Q26778929-6DEC6E92-C237-4FE2-9A47-EDDDEFA28C47 Q35114558-FF4D09ED-ECEF-4244-9747-D8F2B33D0EEE

P2860

Oncostatin M is a FIP1L1/PDGFRA-dependent mediator of cytokine production in chronic eosinophilic leukemia.

Item

http://www.wikidata.org/entity/Q39159911

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Oncostatin M is a FIP1L1/PDGFR ...... chronic eosinophilic leukemia.

@en

Oncostatin M is a FIP1L1/PDGFR ...... chronic eosinophilic leukemia.

@nl

type

Item

label

Oncostatin M is a FIP1L1/PDGFR ...... chronic eosinophilic leukemia.

@en

Oncostatin M is a FIP1L1/PDGFR ...... chronic eosinophilic leukemia.

@nl

prefLabel

Oncostatin M is a FIP1L1/PDGFR ...... chronic eosinophilic leukemia.

@en

Oncostatin M is a FIP1L1/PDGFR ...... chronic eosinophilic leukemia.

@nl

P1476

Oncostatin M is a FIP1L1/PDGFR ...... chronic eosinophilic leukemia.

@en

P2093

A Reiter

http://www.w3.org/2001/XMLSchema#string

A Schmitt-Graeff

http://www.w3.org/2001/XMLSchema#string

H-P Horny

http://www.w3.org/2001/XMLSchema#string

L Müllauer

http://www.w3.org/2001/XMLSchema#string

M Gröger

http://www.w3.org/2001/XMLSchema#string

M Mayerhofer

http://www.w3.org/2001/XMLSchema#string

P Valent

http://www.w3.org/2001/XMLSchema#string

S Cerny-Reiterer

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome

Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome.

Oncostatin M, a multifunctional cytokine

Distinct eosinophil cytokine expression patterns in skin diseases - the possible existence of functionally different eosinophil subpopulations.

Identification of JAK2 as a mediator of FIP1L1-PDGFRA-induced eosinophil growth and function in CEL

Eosinophilic disorders.

Oncostatin M: an interleukin-6-like cytokine relevant to airway remodelling and the pathogenesis of asthma.

Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome

P304

713-723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ALL.12139

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23621172

http://www.w3.org/2001/XMLSchema#string

Oncostatin M is a FIP1L1/PDGFRA-dependent mediator of cytokine production in chronic eosinophilic leukemia.

about

P2860

P2860

Oncostatin M is a FIP1L1/PDGFRA-dependent mediator of cytokine production in chronic eosinophilic leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698